Cours Peloton Therapeutics, Inc.
Actions
PLTX
US70614L1044
Recherche biotechnologique et médicale
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Naseem Zojwalla
CTO | Chief Tech/Sci/R&D Officer | 51 | - |
Corporate Officer/Principal | - | - | |
Peter Stenge
PRN | Corporate Officer/Principal | - | - |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Helen Kim
BRD | Director/Board Member | 61 | 01/11/17 |
Brett A. Ringle
BRD | Director/Board Member | 73 | 01/01/11 |
David Chang
BRD | Director/Board Member | 64 | 01/02/18 |
Varia. 1 janv. | Capi. | |
---|---|---|
+9,58% | 115 Md | |
+12,41% | 107 Md | |
-3,29% | 21,6 Md | |
-12,38% | 22,31 Md | |
-6,87% | 19,19 Md | |
-3,35% | 18,23 Md | |
-38,57% | 17,62 Md | |
+7,51% | 14,26 Md | |
+35,67% | 12,37 Md |